Changes in the rate of problem behavior associated with the discontinuation of the antipsychotic medication quetiapine

Mental Health Aspects of Developmental Disabilities

Volumn 10, Issue 2, 2007, Pages 64-67

  Valdovinos, Maria G ^a   Ellringer, Nicholas P ^a   Alexander, Michelle L ^a  

^a DRAKE UNIVERSITY   (United States)

Author keywords

Aggression; Antidepressant; Antipsychotic; Behavioral analysis; Citalopram; Developmental disability; Intellectual disability; Mental retardation; Psychiatric disorder; Quetiapine; SIB

Indexed keywords

CITALOPRAM; QUETIAPINE;

ADULT; AGGRESSION; ARTICLE; AUTOMUTILATION; BEHAVIOR DISORDER; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MOOD DISORDER;

EID: 34250807823     PISSN: 10573291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Barnard L, Young AH, Pearson J, et al. A systematic review of the use of atypical antipsychotics in autism. J Psychopharmacol 2002;16:93-101.
2. Corson AH, Barkenbus JE, Posey DJ, et al. A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders. J Clin Psychiatry 2004;65:1531-1536.
3. Crosland KA, Zarcone JR, Lindauer SE, et al. Use of functional analysis methodology in the evaluation of medication effects. J Autism Dev Disord 2003;33:271-279.
4. Dicesare A, McAdam DB, Toner A, Varrell J. The effects of methylphenidate on a functional analysis of disruptive behavior: A replication and extension. J Appl Behav Anal 2005;38:125-128.
5. Iwata BA, Dorsey MF, Slifer KJ, et al. Toward a functional analysis of self-injury. J App Behav Anal 1994;27:197-209.
6. (Reprinted from Anal Intervent Dev Disabil 1982;2:3-20.)
7. O'Neill RE, Horner RH, Albin RW, et al. Functional Assessment and Program Development for Problem Behavior. Pacific Grove, CA: Brooks/Cole Publishing, 1997.
8. Schaal DW, Hackenberg T. Toward a functional analysis of drug treatment for behavior problems of people with developmental disabilities. Am J Ment Retard 1994;99:123-140.
9. Shannon HE, Hart JC, Bymaster FP, et al. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats. J Pharmacol Exp Ther 1999;290:901-907.
10. Valdovinos MG, Kennedy CH. Behavior analytic conceptualization of psychotropic medication side effects. Behav Anal 2004;27:231-238.
11. Zarcone JR, Lindauer SE, Morse PS, et al. Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis. Am J Ment Retard 2004;109:310-321.